The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Objective: Bipolar disorder is a chronic, severe and disabling disease; however, its pathophysiology remains poorly understood. Recent evidence has suggested that inflammation and immune dysregulation play a significant role in the pathophysiology of bipolar disorder. This review is aimed to highlight the importance of systemic inflammation in modulating the inflammatory response of microglia and hence its potential involvement with bipolar disorder. We also discuss novel therapeutic strategies that emerge from this new research. Method: This article presents a theoretical synthesis of the effects of systemic inflammation on the immune response of the central nervous system in bipolar disorder. The complex relationship between stress, pro-inflammatory cytokines and microglial dysfunction is summarized, emphasizing the role of the kynurenine pathway in this process and, consequently, their effects on neuronal plasticity. Results: Bipolar patients demonstrate increased serum levels of pro-inflammatory cytokines (interleukin-1β, interleukin-6 and tumor necrosis factor-α) and lower hypothalamic–pituitary–adrenal axis sensitivity. This imbalance in the immune system promotes a change in blood–brain barrier permeability, leading to an inflammatory signal spread in the central nervous system from the periphery, through macrophages activation (M1 polarization). Chronic microglial activation can result in neuronal apoptosis, neurogenesis inhibition, hippocampal volume reduction, lower neurotransmitters synthesis and cytotoxicity, by increasing glutamate production and kynurenine metabolism. Conclusions: This review provides an overview of the mechanisms involved in the immune system imbalance and its potential involvement in the pathophysiology of bipolar disorder. Consequently, new strategies that normalize the immune-inflammatory pathways may provide a valuable therapeutic target for the treatment of these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Global burden of disease in young people aged 10–24 years: a systematic analysis
Gore, F. M., Bloem, P. J., Patton, G. C., Ferguson, J., Joseph, V., Coffey, C., Sawyer, S. M., & Mathers, C. D. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60512-6 · Cited by 2,301 · cited 1×
“By 2020, BD is estimated to become the sixth leading cause of time lost due to disability or death among those aged 15–55 years (Gore et al., 2011).”
BackgroundDrevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 2×
“Australian & New Zealand Journal of Psychiatry, 50(7) (Drevets et al., 2008).”
BackgroundNeuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · cited 5×
“Other researchers have shown that M1 response in peripheral macrophages may be activated by Th1 cells, while the M1 response from microglia could be self-activated through autocrine and paracrine mechanisms (Cherry et al., 2014).”
BackgroundInfluentialRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 2×
“This effect was particularly relevant for patients who had serum CRP levels higher than 5 mg/L than others (Raison et al., 2013).”
BackgroundSo depression is an inflammatory disease, but where does the inflammation come from?
Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., Allen, N. B., Stuart, A. L., Hayley, A. C., Byrne, M. L., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-200 · Cited by 1,423 · cited 3×
“However, the intestinal permeability can be easily altered by factors such as the diet, stressful events, alcohol ingestion and microbiota alteration (Berk et al., 2013).”
BackgroundO'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 2×
“For instance, systemic immune activation by LPS administration may promote neuroinflammation and depressive-like behavior in mice, and these effects seem to be attenuated by chronic antidepressant administration (O’Connor et al., 2009).”
BackgroundKelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110 · cited 3×
“When the intestinal barrier is disrupted, bacteria from the gut can translocate to the lymph nodes and system circulation (Kelly et al., 2015).”
BackgroundMiller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892 · cited 2×
“It is a potent inducer of the inflammatory response, a critical regulator of innate immunity and plays an important role in the regulation of Th1 immune responses against pathogens (Karson et al., 2013; Miller et al., 2013).”
BackgroundIL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · cited 3×
“IL-1β is one of the major pro-inflammatory cytokines inhibiting adult neurogenesis (Koo and Duman, 2008).”
BackgroundInfluentialSteiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791
Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700
Revisiting the Mechanisms of CNS Immune Privilege
Louveau, A., Harris, T. H., & Kipnis, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.006 · Cited by 682 · cited 7×
“At this point, this process should result in the onset of inflammatory response through the activation of adaptive immune cells, such as T-lymphocytes (Louveau et al., 2015a).”
BackgroundInfluentialKroner, A., Greenhalgh, A. D., Zarruk, J. G., Passos dos Santos, R., Gaestel, M., & David, S. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.027 · Cited by 655
Phillips, M. L., & Swartz, H. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13081008 · Cited by 636
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572 · cited 2×
“Furthermore, the release of pro-inflammatory cytokines promotes the BBB disruption—previously described—which could be an alternative for activated monocytes from peripheral blood to access the brain and thus exacerbating the neuroinflammation (Da Fonseca et al., 2014).”
BackgroundRao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432 · cited 2×
“Rao et al. (2010) found a significant increase in c-Fos, inducible nitric oxide synthase messenger RNA (mRNA), protein and mRNA levels of IL-1β and IL-1R, and components of the NFκB, in the post-mortem PFC from BD patients (Rao et al., 2010).”
BackgroundPan, Y., Chen, X.-Y., Zhang, Q.-Y., & Kong, L.-D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.007 · Cited by 405
Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.277 · Cited by 388 · cited 3×
“Australian & New Zealand Journal of Psychiatry, 50(7) involvement of the kynurenine pathway (KYP) in the IL-1β regulation of hippocampal neurogenesis (Zunszain et al., 2012).”
BackgroundInfluentialEvidence for activation of microglia in patients with psychiatric illnesses
Bayer, T. A., Buslei, R., Havas, L., & Falkai, P. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00545-5 · Cited by 323
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318 · cited 1×
“In addition, the use of a GR antagonist (mifepristone RU-486) has been shown to be effective in improving cognitive function in bipolar patients (Young et al., 2004).”
BackgroundAcute inflammation and negative mood: mediation by cytokine activation
Wright, C. E., Strike, P. C., Brydon, L., & Steptoe, A. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2004.10.003 · Cited by 287 · cited 1×
“The activation of the HPA axis is critical in situations of acute inflammation, with the purpose to fight infection through increased production of cortisol in humans, and corticosterone in rodents (Wright et al., 2005).”
BackgroundKim, S., Moon, M., & Park, S. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0132 · Cited by 263 · cited 2×
“For instance, Kim et al. (2009) found that exendin-4, an analog of GLP-1, prevented 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced microglial activation in the substantia nigra and striatum, in a rodent model of Parkinson’s disease.”
BackgroundFrank, M. G., Weber, M. D., Watkins, L. R., & Maier, S. F. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.010 · Cited by 237 · cited 5×
“During chronic inflammation, toxins like lipopolysaccharide (LPS) and other pathogens enhance the release of pro-inflammatory cytokines, HMGB1 and other components that may increase microvascular permeability and lead migration of the leukocytes to the brain parenchyma (Frank et al., 2015; Weber et al., 2015).”
BackgroundInfluentialEndocannabinoids drive the acquisition of an alternative phenotype in microglia
Mecha, M., Feliú, A., Carrillo-Salinas, F. J., Rueda-Zubiaurre, A., Ortega-Gutiérrez, S., de Sola, R. G., & Guaza, C. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.002 · Cited by 234
Weber, M. D., Frank, M. G., Tracey, K. J., Watkins, L. R., & Maier, S. F. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3561-14.2015 · Cited by 215 · cited 3×
“…inflammation, toxins like lipopolysaccharide (LPS) and other pathogens enhance the release of pro-inflammatory cytokines, HMGB1 and other components that may increase microvascular permeability and lead migration of the leukocytes to the brain parenchyma (Frank et al., 2015; Weber et al., 2015).”
BackgroundDiversity and plasticity of microglial cells in psychiatric and neurological disorders
Nakagawa, Y., & Chiba, K. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.010 · Cited by 208 · cited 5×
“Although the consequences of M2b polarization are still unknown, this phenotype is activated under TLRs stimulation by LPS or immune complexes (Nakagawa and Chiba, 2015).”
BackgroundInfluentialSumi, N., Nishioku, T., Takata, F., Matsumoto, J., Watanabe, T., Shuto, H., Yamauchi, A., Dohgu, S., & Kataoka, Y. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9446-7 · Cited by 179 · cited 1×
“This infiltration triggers cytokines release and matrix metalloproteinases (MMPs) activation intensifying BBB disruption and inflammation in the CNS, through glia activation (Sumi et al., 2010).”
BackgroundMonje, F. J., Cabatic, M., Divisch, I., Kim, E.-J., Herkner, K. R., Binder, B. R., & Pollak, D. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1537-11.2011 · Cited by 178 · cited 1×
“Another study from the same group showed that IL-6 induced depressive-like behaviors and impaired proliferation of hippocampal cells that may be mediated by NFκB signaling pathway (Monje et al., 2011).”
BackgroundC-Reactive Protein Alterations in Bipolar Disorder: A Meta-Analysis
Dargél, A. A., Godin, O., Kapczinski, F., Kupfer, D. J., & Leboyer, M. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09007 · Cited by 155 · cited 2×
“…that BD is accompanied by the activation of immune-inflammatory pathways as indicated by the increased levels of pro-inflammatory cytokines, positive acute-phase proteins, complement factors and increased levels of T-cell-related activation markers (Dargél et al., 2015; Rege and Hodgkinson, 2013).”
BackgroundSelf-citationKarson, A., Demirtaş, T., Bayramgürler, D., Balcı, F., & Utkan, T. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12037 · Cited by 143 · cited 2×
“It is a potent inducer of the inflammatory response, a critical regulator of innate immunity and plays an important role in the regulation of Th1 immune responses against pathogens (Karson et al., 2013; Miller et al., 2013).”
BackgroundVieta, E., Reinares, M., & Rosa, A. R. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9197-8 · Cited by 120
Self-citationWatkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100
Pinho, M., Sehmbi, M., Cudney, L. E., Kauer‐Sant'anna, M., Magalhães, P. V., Reinares, M., Bonnín, C. M., Sassi, R. B., Kapczinski, F., Colom, F., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12442 · Cited by 96 · cited 2×
“…in the sleep–wake cycle, such as decreased need for sleep or insomnia/hypersomnia, are Australian & New Zealand Journal of Psychiatry, 50(7) part of the diagnostic criteria for BD. Sleep/wake disturbance has been observed during mood states and even in periods of remission (Pinho et al., 2016).”
BackgroundSelf-citationBonnín, C. D. M., González-Pinto, A., Solé, B., Reinares, M., González-Ortega, I., Alberich, S., Crespo, J. M., Salamero, M., Vieta, E., Martínez-Arán, A., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.034 · Cited by 76 · cited 1×
“Furthermore, poor functioning has been strongly associated with cognitive impairment in bipolar patients (Bonnín Cdel et al., 2014).”
BackgroundDamage‐associated molecular patterns and immune activation in bipolar disorder
Stertz, L., Fries, G. R., Rosa, A. R., Kauer‐Sant'anna, M., Ferrari, P., Paz, A. V. C., Green, C., Cunha, Â. B. M., Dal‐Pizzol, F., Gottfried, C., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12417 · Cited by 53
Self-citationMonfrim, X., Gazal, M., De Leon, P. B., Quevedo, L., Souza, L. D., Jansen, K., Oses, J. P., Pinheiro, R. T., Silva, R. A., Lara, D. R., et al. (2014) · Bipolar Disorders · doi:10.1111/bdi.12214 · Cited by 52
Cited by
Microglia in physiology and disease
Wolf, S. A., Boddeke, H. W. G. M., & Kettenmann, H. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034406 · Cited by 1,426
Inflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
Romijn, A. R., Rucklidge, J. J., Kuijer, R. G., & Frampton, C. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416686694 · Cited by 323
“Email: amy.romijn@southwales.ac.uk Australian & New Zealand Journal of Psychiatry, 51(8) mood disorders (Ascoli et al., 2016; Dowlati et al., 2010; Stefanescu and Ciobica, 2012).”
BackgroundRevisiting inflammation in bipolar disorder
Fries, G. R., Walss-Bass, C., Bauer, M. E., & Teixeira, A. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.006 · Cited by 147
Clinical Phenotype of Depression Affects Interleukin-6 Synthesis
Zadka, Ł., Dzięgiel, P., Kulus, M., & Olajossy, M. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0074 · Cited by 20
Metadata
- Authors
- Ascoli, B. M., Géa, L. P., Colombo, R., Barbé-Tuana, F. M., Kapczinski, F., & Rosa, A. R.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2016-04-18
- Volume
- 50
- Issue
- 7
- Pages
- 618-630
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2340676161
- Cited by
- 40
- References
- 38
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.